Eastwood Bio Medical Canada Stock Performance
| EBM Stock | CAD 0.75 0.05 6.25% |
Eastwood Bio-Medical holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.47, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Eastwood Bio-Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Eastwood Bio-Medical is expected to outperform it. Use Eastwood Bio-Medical maximum drawdown and the relationship between the semi variance and price action indicator , to analyze future returns on Eastwood Bio-Medical.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eastwood Bio Medical Canada are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Eastwood Bio-Medical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Aecon, Intact, Blue Moon Hit 52-Week Highs on News - Baystreet.ca | 10/02/2024 |
| Begin Period Cash Flow | 39.8 K |
Eastwood |
Eastwood Bio-Medical Relative Risk vs. Return Landscape
If you would invest 65.00 in Eastwood Bio Medical Canada on September 1, 2024 and sell it today you would earn a total of 10.00 from holding Eastwood Bio Medical Canada or generate 15.38% return on investment over 90 days. Eastwood Bio Medical Canada is currently producing 2.0484% returns and takes up 21.8772% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Eastwood, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Eastwood Bio-Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eastwood Bio-Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Eastwood Bio Medical Canada, and traders can use it to determine the average amount a Eastwood Bio-Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0936
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | EBM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 21.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.05 actual daily | 40 60% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Eastwood Bio-Medical is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eastwood Bio-Medical by adding it to a well-diversified portfolio.
Eastwood Bio-Medical Fundamentals Growth
Eastwood Stock prices reflect investors' perceptions of the future prospects and financial health of Eastwood Bio-Medical, and Eastwood Bio-Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eastwood Stock performance.
| Return On Equity | -7.47 | ||||
| Return On Asset | -0.64 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.51) % | ||||
| Current Valuation | 51.72 M | ||||
| Shares Outstanding | 68.89 M | ||||
| Price To Earning | (11.43) X | ||||
| Price To Book | 2,943 X | ||||
| Price To Sales | 79.05 X | ||||
| Revenue | 867.94 K | ||||
| Gross Profit | 902.74 K | ||||
| EBITDA | (398.19 K) | ||||
| Net Income | (546.6 K) | ||||
| Cash And Equivalents | 708.26 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 23.08 K | ||||
| Current Ratio | 3.42 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (16.89 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 51.66 M | ||||
| Total Asset | 489.14 K | ||||
| Retained Earnings | (5.54 M) | ||||
| Working Capital | (1.18 M) | ||||
About Eastwood Bio-Medical Performance
Evaluating Eastwood Bio-Medical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Eastwood Bio-Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eastwood Bio-Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.29) | (1.22) | |
| Return On Capital Employed | 0.39 | 0.29 | |
| Return On Assets | (1.29) | (1.22) | |
| Return On Equity | 0.81 | 0.85 |
Things to note about Eastwood Bio Medical performance evaluation
Checking the ongoing alerts about Eastwood Bio-Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eastwood Bio Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eastwood Bio Medical is way too risky over 90 days horizon | |
| Eastwood Bio Medical has some characteristics of a very speculative penny stock | |
| Eastwood Bio Medical appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 867.94 K. Net Loss for the year was (546.6 K) with profit before overhead, payroll, taxes, and interest of 902.74 K. | |
| Eastwood Bio Medical Canada has accumulated about 708.26 K in cash with (16.89 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 70.0% of the company shares are held by company insiders |
- Analyzing Eastwood Bio-Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eastwood Bio-Medical's stock is overvalued or undervalued compared to its peers.
- Examining Eastwood Bio-Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eastwood Bio-Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eastwood Bio-Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eastwood Bio-Medical's stock. These opinions can provide insight into Eastwood Bio-Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.